Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 255 participants.

Also called NCT07173426

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 255 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07173426
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07173426. Randomized; single masking; primary purpose treatment. Start 2024-12-30 (actual); primary completion 2026-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure
Acronym
BIO-HF
Condition
Heart Failure
Condition
Decompensated Heart Failure
Intervention (Device)
Bioimpedance analysis
Lead sponsor
Mid and South Essex NHS Foundation Trust (class: other)
Collaborator
Anglia Ruskin University (class: other)

Record details

Record id
cardio:ct-nct07173426
Content hash
2760ca798bc66f13587c783e989c5958261c98feacc83100553728901b1e14b6